VOGLITUS 0,3

INDICATIONS:

• VOGLITUS, for the treatment of type 1 and type 2 diabetes. It is specifically used to lower postprandial blood glucose, thus reducing the risk of macrovascular complications.
• Type 1 & Type 2 Diabetes
• Corticosteroid-induced
• Prediabetes

DOSAGE:
Adults: The dosage is 1 tablet, 3 times a day, to be taken at the beginning of each meal.
Elderly: Start with the lower dose (0.2 mg), 1 tablet, 3 times a day, to be taken at the beginning of each meal.

ADDITIONAL INFORMATION:
In its 2014 recommendations, the International Diabetes Federation (IDF) reports data that support the involvement of postprandial hyperglycemia in the development of macro- and microvascular complications of diabetes. It highlights the growing body of evidence supporting a link between postprandial hyperglycemia and several markers of cardiovascular disease, namely oxidative stress, endothelial dysfunction, and carotid intima-media thickness. The European DECODE study demonstrated that postprandial blood glucose may be a better predictor of cardiovascular and fatal mortality than fasting blood glucose. The authors of the latest IDF recommendations point to a possible link between postprandial hyperglycemia and the risk of diabetic retinopathy, diabetic polyneuropathies and the onset of cognitive impairment in elderly patients.